Vaxcyte to release Phase 3 trial data for VAX-31 vaccine candidate

October 4, 2026 5:00 PM

Vaxcyte, Inc. (Nasdaq: PCVX) announced it will host a webcast and conference call on October 5, 2026, at 8:00 a.m ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found